Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of exatecan mesylate in treating children who have relapsed or refractory rhabdomyosarcoma.

Timeline

Start

2003-01

Primary completion

2006-04

Completion

2006-04

Drugs

Indications